期刊文献+

浸润性乳癌组织中miRNA-34a甲基化状态分析 被引量:1

METHYLATION STATUS OF MICRO-RNA-34a IN INVASIVE BREAST CANCER
下载PDF
导出
摘要 目的了解浸润性乳癌组织中miRNA-34a启动子区CpG岛甲基化状态,并分析其临床意义。方法采用甲基化特异性PCR(MSP)技术,检测56例浸润性乳癌病人癌组织及相应癌旁正常乳房组织(距病灶边缘〉5cm)中miRNA-34a上游启动子区CpG岛甲基化情况,并分析其与各临床病理参数之间的关系。结果浸润性乳癌组织中miRNA-34a启动子区甲基化率显著高于癌旁正常乳房组织,差异有显著性(χ~2=5.630,P〈0.05)。浸润性乳癌组织中miRNA-34a启动子区甲基化水平与乳癌组织学分级及腋窝淋巴结转移有相关性,差异有显著性(χ~2=10.920、8.737,P〈0.05),而与其他临床病理参数无关。结论浸润性乳癌组织中miRNA-34a启动子区呈现髙甲基化水平,可能促进了浸润性乳癌的发生发展。对其进行检测有助于乳癌的早期诊断及预后判断。 Objective To understand the methylation status of the CpG islands around the promoter regions of miRNA- 34a in invasive breast cancer; and evaluate its clinical significance. Methods Employing methylation-spcific PCR, the methyla- tion status of miRNA-34a promoter in cancer and adjacent normal tissue (from the edge of cancer 〉 5 cm) in 56 patients with inva- sive breast cancer (IBC) were detected. The correlation between these genetic features and clinical pathology was analyzed. Re- sults The methylation rate of CpG islands around the promoter regions of miRNA-34a in IBC was higher than that in adjacent normal breast tissue (X^2=5.630,P〈0.05). The methylation of the CpG islands around the promoter regions of miRNA 34a in IBC was correlated with its histological grade and axillary lymph node metastasis (X^2 = 10.920,8. 737;P %0.05), but unrelated with other clinical pathology parameters. Conclusion The aberrant hypermethylation of CpG island in the promoter of miRNA-34a may promote the development and progress of invasive breast cancer, a detection of it is conducive to an early diagnosis of the cancer and prediction of its prognosis.
出处 《齐鲁医学杂志》 2016年第4期379-381,共3页 Medical Journal of Qilu
基金 山东省自然科学基金(ZR2012HM089)
关键词 乳房肿瘤 微RNAS DNA甲基化 breast neoplasms microRNAs DNA methylation
  • 相关文献

参考文献14

  • 1TAKAHASHI R U, MIYAZAKI H, OCHIYA T. The role ofmicroRNAs in the regulation of cancer stem cells [J/OL]. Frontiers in Genetics, 2014,4 : 295. http://www.ncbi.nlm.nih. gov/pubmed/24427168.
  • 2KANT N M, THRASHER A J, ANGELINI G D, et al. Mi- croRNAs as modulators of stem cells and angiogencsis[J/OL]. Stem Cells, 2014, dot: 10. 1002/stein. 1 629. EEpub ahead of print].
  • 3房建凯,陈枉枉,郭玲玲.miRNA-411对乳癌细胞侵袭和迁移的影响[J].齐鲁医学杂志,2015,30(6):637-640. 被引量:2
  • 4JONES P A, BAYLIN S B. The epigenomics of cancer[J]. Cell, 2007,128(4) :683-692.
  • 5赵蕊,严启滔,吕静野,黄海丽,马文丽.5-氮杂胞苷对结肠癌细胞CHD5基因表达及细胞增殖活性的影响[J].基础医学与临床,2013,33(8):976-980. 被引量:3
  • 6IORIO M V, FERRACIN M, LIU C G, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Canc- er Research, 2005,65(16) :7065-7070.
  • 7LI L S, YUAN L J, LUO J M, et al. MiR-34a inhibits proli- feration and migration of breast cancer through down-regula tion of Bcl-2 and SIRTl[J].Clinical and Experimental Medi- cine, 2013,13(2) =109-117.
  • 8TOI M, OHASHI Y, SEOW A, et al. The breast cancer working group presentation was divided into three sections= the epidemiolo- gy, pathology and treatment of breast cancer[J]. Japanese Journal of Clinical Oncology, 2010,40(1) : i13-i18.
  • 9VOGT M, MUNDING J, GRUNER M, et al. Frequent con- comitant inactivation of miR-34a and miR-34b/c by CpG meth- ylation in colorectal, pancreatic, mammary, ovarian, urothe- lial, and renal cell carcinomas and soft tissue sarcomas[J]. Virchows Archly= an International Journal of Pathology, 2011,458(3), 313-322.
  • 10WONG K Y, YU L, CHIM C S. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family [J]. Epigenomics, 2011,3(1) 783-92.

二级参考文献19

  • 1Sharrard RM,Royds JA,Rogers S,et al. Patterns of methy-lation of the c-myc gene in human colorectal cancer progres-sion [J ].Br J Cancer, 1992,65 : 667 -672.
  • 2White PS, Thompson PM, Gotoh T, et al. Definition andcharacterization of a region of lp36. 3 consistently deleted inneuroblastoma [ J ] . Oncogene ,2005 ,24 : 2684 - 2694.
  • 3Piaskowski S,Rieske P,Szybka M,et al. GADD45A andEPB41 as tumor suppressor genes in meningioma pathogene-sis [ J ]. Cancer Genet Cytogenet, 2005 ,162 : 63 —67.
  • 4Fujita T, Igarashi J, Okawa ER, et al. CHD5, a tumorsuppressor gene deleted from lp36. 31 in neuroblastomas[J]. J Natl Cancer Inst, 2008,100:940 -949.
  • 5Thompson PM, Gotoh T, Kok, et al. CHD5 , a new mem-ber of the chromodomain gene family, is preferentially ex-pressed in the nervous system [ J ]. Oncogene, 2003,22 :1002-1011.
  • 6Mulero-Navarro S,Esteller M,Chromatin remodeling factorCHD5 is silenced by promoter CpG island hypermethylationin human cancer [ J]. Epigenetics,2008,3:210-215.
  • 7Zhao R, Yan Q, Lv J, et al. CHD5, a tumor suppressorthat is epigenetically silenced in lung cancer [ J ],LungCancer, 2012,76:324 -331.
  • 8Nguyen CT, Weisenberger DJ, Velicescu M. et al. HistoneH3-lysine 9 methylation is associated with aberrant gene si-lencing in cancer cells and is rapidly reversed by 5-Aza-2,-deoxycytidine[ J]. Cancer Res,2002,62:6456 - 6461.
  • 9SIEGEL R, MA J M, ZOU Z H, et al. Cancer statistics, 2014 [J]. CA-A Cancer Journal for Clinicians, 2014,64(1) :9-29.
  • 10DVINGE H, GIT A, GRAEF S, et al. The shaping and func- tional Consequences of the microRNA landscape in breast cancer[J]. Nature, 2013,497(7449) :378-382.

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部